Skip to main content
Year archive

BioLineRx Ltd. — 2021 filings

All 85 regulatory filings released by BioLineRx Ltd. (BLRX) in 2021, sourced directly from the official regulator.

85 Filings
2021 Period
2021 filings (85)
Filing Released Lang
BioLineRx Provides Highlights from Oral Presentation Delivered at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition
Regulatory Filings
2021-12-17 English
BioLineRx Provides Highlights from Oral Presentation Delivered at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition
Report Publication Announcement
2021-12-17 English
6-K
Foreign Filer Report
2021-12-17 English
6-K
Foreign Filer Report
2021-12-15 English
BioLineRx Announces Formation of Immuno-Oncology Scientific Advisory Board (SAB)
Regulatory Filings
2021-12-15 English
BioLineRx Announces Formation of Immuno-Oncology Scientific Advisory Board (SAB)
Report Publication Announcement
2021-12-15 English
BioLineRx reports results of shareholders meeting which was held on December 2, 2021
AGM Information
2021-12-04 English
BioLineRx reports results of shareholders meeting which was held on December 2, 2021
AGM Information
2021-12-04 English
6-K
Foreign Filer Report
2021-12-03 English
6-K
Foreign Filer Report
2021-11-18 English
BioLineRx Reports Third Quarter 2021 Financial Results and Provides Corporate Update- FORM 6-K
Interim / Quarterly Report Q3 2021
2021-11-18 English
BioLineRx Reports Third Quarter 2021 Financial Results and Provides Corporate Update- FORM 6-K
Report Publication Announcement
2021-11-18 English
6-K
Foreign Filer Report
2021-11-04 English
BioLineRx Announces an Oral Presentation and Three Poster Presentations at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition
Regulatory Filings
2021-11-04 English
BioLineRx Announces an Oral Presentation and Three Poster Presentations at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition
Report Publication Announcement
2021-11-04 English
Immediate Report of Meeting to be held on December 2,2021,Proxy
AGM Information
2021-10-28 English
Immediate Report of Meeting to be held on December 2,2021,Proxy
AGM Information
2021-10-28 English
6-K
Foreign Filer Report
2021-10-27 English
6-K
Foreign Filer Report
2021-10-13 English
BioLineRx Announces Positive Results from Pharmacoeconomic Study Positioning Motixafortide as Potential Standard of Care in Stem Cell Mobilization
Regulatory Filings
2021-10-13 English
BioLineRx Announces Positive Results from Pharmacoeconomic Study Positioning Motixafortide as Potential Standard of Care in Stem Cell Mobilization
Report Publication Announcement
2021-10-13 English
Regulatory Filings 2021
Regulatory Filings
2021-09-21 English
BioLineRx enters into At-The-Market Agreement with H.C. Wainwright & Co., LLC
Regulatory Filings
2021-09-05 English
BioLineRx enters into At-The-Market Agreement with H.C. Wainwright & Co., LLC
Regulatory Filings
2021-09-05 English
PROSPECTUS SUPPLEMENT – ATM
Capital/Financing Update
2021-09-05 English
PROSPECTUS SUPPLEMENT – ATM
Report Publication Announcement
2021-09-05 English
6-K
Foreign Filer Report
2021-09-03 English
424B5
Prospectus
2021-09-03 English
COVER
Foreign Filer Report
2021-08-18 English
BioLineRx Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Earnings Release Q2 2021
2021-08-18 English
BioLineRx Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Report Publication Announcement H1 2021
2021-08-18 English
6-K
Foreign Filer Report
2021-05-26 English
BioLineRx Reports First Quarter 2021 Financial Results and Provides Corporate Update
Interim / Quarterly Report Q1 2021
2021-05-26 English
BioLineRx Reports First Quarter 2021 Financial Results and Provides Corporate Update
Report Publication Announcement
2021-05-26 English
6-K
Foreign Filer Report
2021-05-04 English
Positive Top-Line Results from GENESIS Phase 3 Trial of Motixafortide in Stem-Cell Mobilization for Autologous Bone Marrow Transplantation in Multiple Myeloma Patients
Regulatory Filings
2021-05-04 English
Positive Top-Line Results from GENESIS Phase 3 Trial of Motixafortide in Stem-Cell Mobilization for Autologous Bone Marrow Transplantation in Multiple Myeloma Patients
Report Publication Announcement
2021-05-04 English
BioLineRx Announces Presentation at 2021 American Association for Cancer Research (AACR) Annual Meeting
Regulatory Filings
2021-04-17 English
BioLineRx Announces Presentation at 2021 American Association for Cancer Research (AACR) Annual Meeting
Report Publication Announcement
2021-04-17 English
6-K
Foreign Filer Report
2021-04-15 English
Results of Extraordinary General Meeting of Shareholders which was held on April 5, 2021
Declaration of Voting Results & Voting Rights Announcements
2021-04-05 English
Results of Extraordinary General Meeting of Shareholders which was held on April 5, 2021
Declaration of Voting Results & Voting Rights Announcements
2021-04-05 English
6-K
Foreign Filer Report
2021-04-05 English
Immediate Report of Meeting to be held on April 5, 2021,proxy statement
Proxy Solicitation & Information Statement
2021-02-27 English
Immediate Report of Meeting to be held on April 5, 2021,proxy statement
Proxy Solicitation & Information Statement
2021-02-27 English
Immediate Report of Meeting to be held on April 5, 2021,proxy statement
AGM Information
2021-02-27 English
6-K
Foreign Filer Report
2021-02-26 English
Regulatory Filings 2021
Regulatory Filings
2021-02-25 English
POS AM
Regulatory Filings
2021-02-23 English
6-K
Foreign Filer Report
2021-02-23 English
20-F
Annual Report FY 2020
2021-02-23 English
Post-Effective Amendment No.2
Capital/Financing Update
2021-02-23 English
Post-Effective Amendment No.2
Capital/Financing Update
2021-02-23 English
Form 20-F 2020
Annual Report FY 2020
2021-02-23 English
Form 20-F 2020
Report Publication Announcement
2021-02-23 English
Reports Year-End 2020 Financial Results and Provides Corporate Update
Regulatory Filings
2021-02-23 English
Reports Year-End 2020 Financial Results and Provides Corporate Update
Report Publication Announcement
2021-02-23 English
SC 13G/A
Major Shareholding Notification
2021-02-16 English
AMENDMENT TO SCHEDULE 13G
Major Shareholding Notification
2021-02-13 English
BIOLINERX LTD.
Major Shareholding Notification
2021-02-12 English
AMENDMENT NO. 1 TO SCHEDULE 13G
Major Shareholding Notification
2021-01-29 English
PRELIMINARY PROSPECTUS SUPPLEMENT dated January 11, 2021
Capital/Financing Update
2021-01-23 English
PRELIMINARY PROSPECTUS SUPPLEMENT dated January 11, 2021
Capital/Financing Update
2021-01-23 English
Closing of $34.5 Million Bought Deal Offering and Full Exercise of the Option of the Underwriter
Regulatory Filings
2021-01-23 English
Closing of $34.5 Million Bought Deal Offering and Full Exercise of the Option of the Underwriter
Report Publication Announcement
2021-01-23 English
6-K
Foreign Filer Report
2021-01-22 English
6-K
Foreign Filer Report
2021-01-21 English
424B5
Prospectus
2021-01-21 English
BioLineRx Increases Previously Announced Bought Deal Offering to $30 Million
Share Issue/Capital Change
2021-01-20 English
BioLineRx Increases Previously Announced Bought Deal Offering to $30 Million
Capital/Financing Update
2021-01-20 English
FWP
Regulatory Filings
2021-01-20 English
Preliminary Prospectus Supplement (to prospectus dated January 11, 2021)
Capital/Financing Update
2021-01-19 English
Preliminary Prospectus Supplement (to prospectus dated January 11, 2021)
Regulatory Filings
2021-01-19 English
Announces $10 Million Bought Deal Offering
Capital/Financing Update
2021-01-19 English
Announces $10 Million Bought Deal Offering
Capital/Financing Update
2021-01-19 English
FWP
Regulatory Filings
2021-01-19 English
424B5
Prospectus
2021-01-19 English
Regulatory Filings 2021
Regulatory Filings
2021-01-12 English
Regulatory Filings 2021
Regulatory Filings
2021-01-11 English
SABBY 13G-A BLRX 1.06.21
Major Shareholding Notification
2021-01-06 English
Regulatory Filings 2021
Regulatory Filings
2021-01-06 English
PROSPECTUS SUPPLEMENT Dated December 31, 2020
Capital/Financing Update
2021-01-02 English
PROSPECTUS SUPPLEMENT Dated December 31, 2020
Report Publication Announcement
2021-01-02 English
Shelf Registration Statement
Capital/Financing Update
2021-01-02 English
Shelf Registration Statement
Capital/Financing Update
2021-01-02 English